threat to distribution channels of the Company’s customers and they had to postpone their purchase orders of the Company’s products. Moreover, there were a number of incidents that adversely affected

(Microsoft Word - MPIC - 4150514765052264 E) -Translation – MPIC 013/2018 August 8, 2018 Subject: Notification of the investment in the distribution company in Cambodia Attn: The President The Stock

Administration (CFDA) at the beginning of 2 0 1 8 as the Company had to redesign its packaging to comply with the requirements of the license. Furthermore, the Company also found it necessary to adjust its sales

reducing production cost and also negotiating with customers to review and adjust selling price every quarter. 2.2. Distribution costs for 2018 was in the amount of 4.95 million baht, increased by 1.16

granted a license from China Food and Drug Administration (CFDA) during the beginning of 2018 as the Company had to redesign and adjust product packaging according to the granted license as well as change

issued from China Food and Drug Administration (CFDA) at the beginning of 2018 as the Company had to redesign its packaging to comply with the requirements of the license and adjust its sales structures

consistent increase in its retail channel sales; the main distribution channel, from the Company’s strategy to enlarge its customer base, and debuted the B20 Diesel product in tandem with a special price

the COVID-19 outbreak result of crude premium to adjust downward with significance. Despite the finished product and reference crude price crack spread for most products had been declining continuously

) to review and adjust the assumptions for cash flows projections of those subsidiaries to calculate the recoverable amount appropriately, and to consider the adequacy and appropriateness of the

from 79.01 Million Baht to 74.65 Million Baht or 5.52% due to cancellation of licensor distribution and manufacturing. This affects extensive project cannot apply tender as a results. 2. The Company’s